Tumour necrosis factor-α production during cytomegalovirus infection in immunosuppressed rats

References

1. Aderka D., Holtmann H., Toker L., Fiahn T., Wallach D. 1986; Tumor necrosis factor induction by Sendai virus. Journal of Immunology 136:2938–2942
   [Google Scholar]
2. Beutler B., Cerami A. 1987; Cachectin: more than a tumor necrosis factor. New England Journal of Medicine 316:379–383
   [Google Scholar]
3. Billiau A. 1987; Redefining interferon: the interferon-like antiviral effects of certain cytokines (interleukin-1, interferon-β ₂, interferon-γ) may be indirect or side effects. Antiviral Research 8:55–70
   [Google Scholar]
4. Bruggeman C. A., Meijer H., Dormans P. H. J., Debie W. H. M., Grauls G.E.L.M., Van Boven C. P. A. 1982; Isolation of a cytomegalovirus-like agent. Archives of Virology 73:231–241
   [Google Scholar]
5. Dinarello C. A. 1989; Interleukin-1 and its biologically related cytokines. Advances in Immunology 44:153–205
   [Google Scholar]
6. Dudding L., Haskill S., Clark B. D., Auron P. E., Sporn S., Huang E.-S. 1989; Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes. Journal of Immunology 143:3343–3352
   [Google Scholar]
7. Duh E. J., Maury W. J., Folks T. M., Fauci A. S., Rabson A. B. 1989; Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF- kB sites in the long terminal repeat. Proceedings of the National Academy of Sciences U.S.A.: 865974–5978
   [Google Scholar]
8. Espevik T., Nissen-Meyer J. 1986; A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. Journal of Immunological Methods 95:99–107
   [Google Scholar]
9. Fiala M., Cone L. A., Chang C., Mocarski E. S. 1986; Cytomegalovirus viraemia increases with progressive immune deficiency in patients infected with HTLV-III. AIDS Research 2:175–181
   [Google Scholar]
10. Ginsberg H. S., Moldawer L. L., Sehgal P. B., Reddington M., Kilian P., Chanock R. M., Prince G. A. 1991; A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proceedings of the National Academy of Sciences U.S.A.: 881651–1655
    [Google Scholar]
11. Grau G. E., Fajardo L. F., Piguet P.-F., Allet B., Lambert P.-H., Vassali P. 1987; Tumor necrosis factor (cachectin) as a essential mediator in murine cerebral malaria. Science 237:1210–1212
    [Google Scholar]
12. Grundy J. E., Shanley J. D., Griffiths P. D. 1987; Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?. Lancet ii:996–999
    [Google Scholar]
13. Haagmans B. L., Stals F. S., Van Der Meide P. H., Bruggeman C. A., Horzinek M. C., Schijns V. E. C. J. 1994; Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. Journal of Virology in press
    [Google Scholar]
14. Hallahan D. E., Spriggs D. R., Beckett M. A., Kufe D. W., Weichselbaum R. R. 1989; Increased tumor necrosis factor a mRNA after cellular exposure to ionizing radiation. Proceedings of the National Academy of Sciences U.S.A.: 8610104–10107
    [Google Scholar]
15. Han J., Brown T., Beutler B. 1990; Endotoxin-responsive sequences control cachectin/TNF biosynthesis at the translational level. Journal of Experimental Medicine 171:465–175
    [Google Scholar]
16. Helle M., Boeije L., Aarden L. A. 1988; Functional discrimination between interleukin 6 and interleukin 1. European Journal of Immunology 18:1535–1540
    [Google Scholar]
17. Ho M. 1982; Human cytomegalovirus infections in immuno-suppressed patients. In Cytomegalovirus, Biology and Infection: Current Topics in Infectious Disease pp 171–204 Greenough W. B., Merigan T. C. Edited by New York: Plenum Press;
    [Google Scholar]
18. Koper J. W., Lopes Cardozo M., Romhn H. J., Van Golde L. M. G. 1984; Culture of rat cerebral oligodendrocytes in a serum- free chemically defined medium. Journal of Neuroscience Methods 10:157–169
    [Google Scholar]
19. Macher A. M., Reichert C. M., Straus S. E., Longo D. L., Parrillo J., Lane H. C., Fauci A. S., Rook A. H., Mani-Schewitz J. F., Quinnan G. V. 1983; Death in the AIDS patient. Role of cytomegalovirus. New England Journal of Medicine 309:1454
    [Google Scholar]
20. Merrill J. E., Koyanagi Y., Chen I. S. Y. 1989; Interleukin-1 and tumor necrosis factor α can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. Journal of Virology 63:4404–4409
    [Google Scholar]
21. Meyers J. D., Flournoy N., Thomas E. D. 1986; Risk factors for cytomegalovirus infection after human marrow transplantation. Journal of Infectious Diseases 153:478–488
    [Google Scholar]
22. Moore M. A., Warren D. J. 1987; Synergy of interleukin-1 and granulocyte colony-stimulating factor: in vivo stimulation of stemcell recovery and hematopoietic regeneration following 5-fluoro- uracil treatment of mice. Proceedings of the National Academy of Sciences U.S.A.: 847134–7137
    [Google Scholar]
23. Schijns V.E.C.J., Van Der Neut R., Haagmans B. L., Bar D. R., Schellekens H., Horzinek M. C. 1991; Tumour necrosis factor-α, interferon-γ and interferon-β exert antiviral activity in nervous tissue cells. Journal of General Virology 12:809–815
    [Google Scholar]
24. Sheenan K. C. F., Ruddle N. H., Schreiber R. D. 1989; Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. Journal of Immunology 142:3884–3893
    [Google Scholar]
25. Smith P. D., Saini S. S., Raffeld M., Manischewitz J. F., Wahl S. M. 1992; Cytomegalovirus induction of tumor necrosis factor-a by human monocytes and mucosal macrophages. Journal of Clinical Investigation 90:1642–1648
    [Google Scholar]
26. Stals F. S., Bosman F., Van Boven C. P. A., Bruggeman C. A. 1990; An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Archives of Virology 114:91–107
    [Google Scholar]
27. Tilg H., Vogel W., Herold M., Aulitzky W. E., Huber C. 1991; Cachexia and tumor necrosis factor-α in cytomegalovirus infection. Journal of Clinical Pathology 44:519–520
    [Google Scholar]
28. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R, Fahey T. J., Zentella A., Albert J. D., Shires G. T., Cerami A. 1986; Shock and tissue injury induced by recombinant human cachectin. Science 234:470–474
    [Google Scholar]
29. Van Dene Ertwegh A. J. M., Fasbender M. J., Schellekens M. M., Van Oudenaren A., Boersma W. J. A., Claassen E. 1991; In vivo kinetics and characterization of IFN-γ-producing cells during a thymus-independent immune response. Journal of Immunology 147:439–446
    [Google Scholar]
30. Van Snick J. 1990; Interleukin-6: an overview. Annual Review of Immunology 8:253–278
    [Google Scholar]
31. Vassali P. 1992; The pathophysiology of tumor necrosis factors. Annual Review of Immunology 10:411–452
    [Google Scholar]
32. Wong G. H. W., Goeddel D. V. 1986; Tumour necrosis factors a and p inhibit virus replication and synergize with interferons. Nature; London: 323819–822
    [Google Scholar]